Synthorx to Present at H.C. Wainwright 21st Annual Global Investment Conference
August 29 2019 - 3:05PM
Synthorx, Inc. (NASDAQ: THOR), a clinical-stage biotechnology
company developing optimized therapeutics for cancer and autoimmune
disorders, today announced the Company will present at the H.C.
Wainwright 21st Annual Global Investment Conference on Monday,
September 9 at 10:25 a.m. ET in New York, NY.
The live webcast of the company’s presentation will be available
at Synthorx’s investor relations website. An archived replay
will be available for 30 days following the presentation.
To receive Synthorx’s press releases and other investor
information, please visit the Investor Relations page of the
company’s website and register for email alerts.
About SynthorxSynthorx, Inc. is a
clinical-stage biotechnology company focused on prolonging and
improving the lives of people with cancer and autoimmune disorders.
Synthorx’s proprietary, first-of-its-kind Expanded Genetic Alphabet
platform technology expands the genetic code by adding a new DNA
base pair and is designed to create optimized biologics, referred
to as Synthorins. A Synthorin is a protein optimized through
incorporation of novel amino acids encoded by the new DNA base pair
that enables site-specific modifications, which enhance the
pharmacological properties of these therapeutics. The company’s
lead product candidate, THOR-707, a variant of IL-2, is in
development in multiple tumor types as a single agent and in
combination with an immune checkpoint inhibitor. The company was
founded based on important discoveries by Dr. Floyd Romesberg and
The Scripps Research Institute. Synthorx is headquartered in La
Jolla, Calif. For more information, visit www.synthorx.com.
Investor Relations Contacts: Enoch Kariuki,
Pharm.D.Synthorx, Inc.ekariuki@synthorx.com 858-750-4750
Christina TartagliaStern IR,
Inc.christina.tartaglia@sternir.com212-362-1200
Media Relations Contact:Lauren
FishCanale Communicationslauren@canalecomm.com619-849-5386
Synthorx (NASDAQ:THOR)
Historical Stock Chart
From Jun 2024 to Jul 2024
Synthorx (NASDAQ:THOR)
Historical Stock Chart
From Jul 2023 to Jul 2024
Real-Time news about Synthorx Inc (NASDAQ): 0 recent articles
More News Articles